Drugs / Vanish XT varnish
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06696105 | Aug 2024 → Jun 2025 overdue | dental enamel hypoplasia, smooth surface dental caries | King Abdulaziz University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vanish XT varnish | “Group B: "Vanish™ XT varnish" (n=44 teeth):” NCT06696105 ↗ |
| Known as | VanishTM XT varnish | “The goal of this clinical trial is to assess the efficacy of "Icon® resin infiltration" and "VanishTM XT varnish" in restoring the appearance of white spot lesions WSLs in...” NCT06696105 ↗ |